Correlation Between Scopus Biopharma and Salarius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Scopus Biopharma and Salarius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scopus Biopharma and Salarius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scopus Biopharma and Salarius Pharmaceuticals, you can compare the effects of market volatilities on Scopus Biopharma and Salarius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scopus Biopharma with a short position of Salarius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scopus Biopharma and Salarius Pharmaceuticals.
Diversification Opportunities for Scopus Biopharma and Salarius Pharmaceuticals
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Scopus and Salarius is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Scopus Biopharma and Salarius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Salarius Pharmaceuticals and Scopus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scopus Biopharma are associated (or correlated) with Salarius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Salarius Pharmaceuticals has no effect on the direction of Scopus Biopharma i.e., Scopus Biopharma and Salarius Pharmaceuticals go up and down completely randomly.
Pair Corralation between Scopus Biopharma and Salarius Pharmaceuticals
Given the investment horizon of 90 days Scopus Biopharma is expected to generate 2.72 times more return on investment than Salarius Pharmaceuticals. However, Scopus Biopharma is 2.72 times more volatile than Salarius Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Salarius Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 25.00 in Scopus Biopharma on September 3, 2024 and sell it today you would lose (15.00) from holding Scopus Biopharma or give up 60.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 7.88% |
| Values | Daily Returns |
Scopus Biopharma vs. Salarius Pharmaceuticals
Performance |
| Timeline |
| Scopus Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Salarius Pharmaceuticals |
Scopus Biopharma and Salarius Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scopus Biopharma and Salarius Pharmaceuticals
The main advantage of trading using opposite Scopus Biopharma and Salarius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scopus Biopharma position performs unexpectedly, Salarius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salarius Pharmaceuticals will offset losses from the drop in Salarius Pharmaceuticals' long position.| Scopus Biopharma vs. Scpharmaceuticals | Scopus Biopharma vs. DiaMedica Therapeutics | Scopus Biopharma vs. Monopar Therapeutics | Scopus Biopharma vs. Pasithea Therapeutics Corp |
| Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Histogen | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. Aileron Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |